Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000725654 | SCV000338384 | uncertain significance | not provided | 2016-01-26 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000725654 | SCV000719280 | likely benign | not provided | 2019-11-13 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001397437 | SCV001599184 | likely benign | Early infantile epileptic encephalopathy with suppression bursts | 2024-01-08 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002374464 | SCV002625622 | likely benign | Inborn genetic diseases | 2017-07-17 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000725654 | SCV004700277 | likely benign | not provided | 2023-12-01 | criteria provided, single submitter | clinical testing | SCN8A: BP7 |
Prevention |
RCV003967745 | SCV004781554 | likely benign | SCN8A-related condition | 2019-08-29 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |